Spyre Therapeutics Inc (SYRE)

Cost of Revenue

$90.49M

TTM · Period ending: · USD

SYRE logo

SYRE Cost of Revenue

Latest reported$90.49M
SYRE TTM Cost of Revenue ($0.00 → $90.49M)
High-resolution chart · PNG

SYRE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Spyre Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
90,494,000
90,494,000
90,494,000
45,247,000
0
0
0
0
0
0
548,000
1,038,000
1,540,000
2,015,000
1,964,000
1,976,000
16,327,000
29,431,000
28,934,000
28,432,000
13,579,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.